A successful approach to overcome imatinib-induced skin toxicity in a GIST patient

Since the introduction of tyrosine kinase inhibitors in gastrointestinal stromal tumor patients, the median survival of patients has increased from less than 1 to more than 5 years. The chronic use of a tyrosine kinase inhibitor has an impact on quality of life because of its toxicity. Adequate supp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anti-cancer drugs 2016-07, Vol.27 (6), p.576-579
Hauptverfasser:	Desar, Ingrid M.E, van Herpen, Carla M.L, van Erp, Nielka P, Kaal, Suzanne E.J, van de Kerkhof, Peter C.M, van der Graaf, Winette T.A
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Clemastine - therapeutic use Doxycycline - therapeutic use Female Gastrointestinal Stromal Tumors - drug therapy Gastrointestinal Stromal Tumors - pathology Humans Imatinib Mesylate - adverse effects Imatinib Mesylate - therapeutic use Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Skin Diseases - chemically induced Skin Diseases - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!